TATA Health International Holdings Limited (HKG:1255)
Hong Kong
· Delayed Price · Currency is HKD 1.800
0.00 (0.00%)
Apr 29, 2026, 3:17 PM HKT
HKG:1255 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 99.8 | 124.46 | 207.54 | 144.61 | 160.93 | Upgrade
|
| Revenue Growth (YoY) | -19.81% | -40.03% | 43.52% | -10.14% | 3.58% | Upgrade
|
| Cost of Revenue | 19.54 | 39.51 | 56.78 | 30.66 | 56.21 | Upgrade
|
| Gross Profit | 80.26 | 84.95 | 150.76 | 113.94 | 104.72 | Upgrade
|
| Selling, General & Admin | 103.09 | 125.04 | 180.97 | 145.63 | 162.92 | Upgrade
|
| Operating Expenses | 103.57 | 124.09 | 182.3 | 145.61 | 162.92 | Upgrade
|
| Operating Income | -23.31 | -39.14 | -31.54 | -31.67 | -58.2 | Upgrade
|
| Interest Expense | -2.8 | -4.25 | -1.66 | -2.49 | -2.76 | Upgrade
|
| Interest & Investment Income | - | 2.92 | 2.45 | 1.45 | 1.19 | Upgrade
|
| Earnings From Equity Investments | - | - | -0.21 | -0.4 | -0.57 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.01 | -0.03 | -0.01 | -0.47 | Upgrade
|
| Other Non Operating Income (Expenses) | 43.61 | 5.72 | 2 | 3.8 | -4.22 | Upgrade
|
| EBT Excluding Unusual Items | 17.51 | -34.73 | -28.99 | -29.33 | -65.04 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.21 | - | -1.51 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -5.62 | -0.08 | 32.96 | 0.35 | Upgrade
|
| Asset Writedown | -3.52 | -11.96 | -7.02 | -0.6 | -2.66 | Upgrade
|
| Other Unusual Items | - | -15.72 | 0.46 | -0.53 | -0.29 | Upgrade
|
| Pretax Income | 13.99 | -68.03 | -35.42 | 2.5 | -69.14 | Upgrade
|
| Income Tax Expense | 0.64 | 0.31 | 0.63 | 0.9 | 1.31 | Upgrade
|
| Earnings From Continuing Operations | 13.35 | -68.34 | -36.05 | 1.6 | -70.45 | Upgrade
|
| Minority Interest in Earnings | - | - | 3.75 | 6.45 | 9.69 | Upgrade
|
| Net Income | 13.35 | -68.34 | -32.29 | 8.05 | -60.76 | Upgrade
|
| Net Income to Common | 13.35 | -68.34 | -32.29 | 8.05 | -60.76 | Upgrade
|
| Shares Outstanding (Basic) | 243 | 243 | 243 | 243 | 232 | Upgrade
|
| Shares Outstanding (Diluted) | 243 | 243 | 243 | 243 | 232 | Upgrade
|
| Shares Change (YoY) | - | - | - | 4.67% | 8.42% | Upgrade
|
| EPS (Basic) | 0.05 | -0.28 | -0.13 | 0.03 | -0.26 | Upgrade
|
| EPS (Diluted) | 0.05 | -0.28 | -0.13 | 0.03 | -0.26 | Upgrade
|
| Free Cash Flow | - | -3.56 | 33.8 | 12.12 | -5.98 | Upgrade
|
| Free Cash Flow Per Share | - | -0.01 | 0.14 | 0.05 | -0.03 | Upgrade
|
| Gross Margin | 80.43% | 68.26% | 72.64% | 78.80% | 65.07% | Upgrade
|
| Operating Margin | -23.35% | -31.45% | -15.20% | -21.90% | -36.17% | Upgrade
|
| Profit Margin | 13.38% | -54.91% | -15.56% | 5.56% | -37.76% | Upgrade
|
| Free Cash Flow Margin | - | -2.86% | 16.28% | 8.38% | -3.71% | Upgrade
|
| EBITDA | -11.76 | -36.74 | -30.37 | -30.56 | -56.79 | Upgrade
|
| EBITDA Margin | -11.78% | -29.52% | -14.63% | -21.13% | -35.29% | Upgrade
|
| D&A For EBITDA | 11.55 | 2.4 | 1.17 | 1.11 | 1.41 | Upgrade
|
| EBIT | -23.31 | -39.14 | -31.54 | -31.67 | -58.2 | Upgrade
|
| EBIT Margin | -23.35% | -31.45% | -15.20% | -21.90% | -36.17% | Upgrade
|
| Effective Tax Rate | 4.55% | - | - | 35.96% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.